Pharmacogenomics IND Commercial SNP Clinical Study - Abiraterone and Single Nucleotide Polymorphisms
Clinical trial NCT03348670 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03348670
- Sponsor
- Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-18
- Primary completion
- 2026-11-18
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.